Adjunctive vagus nerve stimulation associated with reduced neurobehavioral symptoms in chronic mTBI with PTSD
This was a retrospective post-hoc subgroup analysis of adults with chronic mild traumatic brain injury (mTBI) symptoms and comorbid PTSD, defined by a PCL-5 score ≥31. The study examined the association of adjunctive non-invasive vagus nerve stimulation (nVNS) with symptom changes over a 3–4 month follow-up period, using within-group comparisons from baseline.
The primary outcome was the change in total Neurobehavioral Symptom Inventory (NSI) score. Mean total NSI scores decreased from 2.50 ± 0.60 at baseline to 2.03 ± 0.46 at follow-up, representing a significant reduction in overall symptom burden (FDR-corrected, q). Secondary outcomes included changes in NSI symptom domains and item-level responses, though specific results were not reported.
Safety and tolerability data were not reported; no adverse events, serious adverse events, or discontinuations were described. The study had no comparator group, and the sample size and setting were not reported.
Key limitations include the post-hoc, retrospective design, absence of a control group, and unreported sample size. The findings are preliminary and associative, not causal. Practice relevance was not reported, and clinicians should not generalize beyond the reported subgroup or infer real-world impact without direct evidence.